Articles tagged with “health-technology-assessment”

HTA Dossiers: A Guide to Submissions for NICE, CADTH & ICER

An in-depth guide to HTA dossiers. Explore the evidence requirements, economic models, and submission templates for NICE (UK), CADTH (Canada), and ICER (US).

55 min read

1/9/2026

hta dossier health technology assessment market access nice submission cadth icer cost-effectiveness analysis reimbursement submission

QALYs & ICERs Explained: Core Health Economics Metrics

An educational guide to QALYs and ICERs, the core metrics in health economics. Learn how they measure value and guide cost-effectiveness decisions. Updated April 2026 with NICE's new £25k–£35k/QALY threshold.

45 min read

1/8/2026

qaly icer health economics cost-effectiveness analysis cost-utility analysis health technology assessment nice threshold willingness to pay

ICER vs NICE: How the US & UK Assess Drug Value & Price

An in-depth comparison of ICER (US) vs NICE (UK). Explore their methods, QALY thresholds, and how they assess drug value to influence global pricing floors.

50 min read

1/8/2026

icer vs nice health technology assessment drug pricing cost-effectiveness qaly value-based pricing drug value assessment

LLMs for Clinical Evidence: Automating Economic Dossiers

Analysis of how Large Language Models (LLMs) automate clinical evidence collection for HTA economic dossiers. Covers systematic reviews, data extraction, and ch

35 min read

1/7/2026

large language models health technology assessment economic dossiers clinical evidence synthesis systematic literature review ai in pharma gpt-4 ai